Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003142 Injection Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and Multiple-ascending Doses in Chinese Healthy Adult Subjects
Latest Information Update: 08 Apr 2024
At a glance
- Drugs JMKX-003142 (Primary)
- Indications Heart failure; Kidney disorders; Oedema
- Focus Adverse reactions
- Sponsors Jemincare
Most Recent Events
- 08 Apr 2024 New trial record